PATENT CLAIM ANALYSIS

Application Number: 15751709
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
Compositions comprising S1P receptor modulators and at least one compound selected from one or more of the group consisting of steroids, opioids and non-steroidal anti-inflammatory drugs are provided. The compositions find use in the treatment of disease, particularly inflammation and immune mediated disorders.

Claim (Index 8):
A composition according to  claim 3 , wherein the compound of formula (I) has the formula wherein R 1  is selected from F, Cl, Br, CN, CF 3 , Me, NO 2 , OMe, OEt, OPr, O-iPr, O-isobutyl, O-isopentyl, O-cyclopentyl, O-allyl, O-benzyl and wherein R 2  is H; wherein R 3  is selected from H, deuterium, Pr, butyl, OMe, OEt, OPr, OiPr, O-isobutyl, O-isopentyl, O-butyl, O-pentyl, O-cyclopentyl, O-allyl, O-benzyl and wherein R 4  is selected from H, deuterium, Me and Et; wherein R is selected from H, Me or \u2014CH 2 OH; wherein R\u2032 is selected from H and Me; wherein L is H; and wherein A is not present.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.20513
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12176279', '12119311', '12913363', '12978087', '13604152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7666985821967014
- 35 USC 102 Novelty (BERT): 0.477519128307392
- Combined Prediction Score: 0.7377806368077705
- Mean Citation Score: 188.709352
- Max Citation Score: 193.54948
- Similarity Product: 151.9319053435564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test